RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Alternate-day dosing of linagliptin in type 2 diabetes patients controlled on once daily dose: A case series.

Alternate-day dosing of linagliptin in type 2 diabetes patients controlled on once daily dose: A case series.

Add to Collection
2016 Jul-Aug Case Reports MP Baruah, SB Bhuyan, J Deka, J Bora… - Indian Journal of …, 2016 - ncbi.nlm.nih.gov

Full Author : ['Baruah, Manash P', 'Bhuyan, Sonali B', 'Deka, Jumi', 'Bora, Jatin', 'Bora, Smritisikha', 'Barkakati, Murchana']
Journal Title : Indian journal of endocrinology and metabolism
Chapter : Section4
Journal Year : 2016
Cited by : 3

Linagliptin, a dipeptidyl peptidase 4 (DPP 4) inhibitor with a long terminal half life, significantly inhibits the DPP 4 enzyme at a steady state up to 48 h after the last dose. The present case series examined the hypothesis that linagliptin retains its ..... Read More

Keywords : ['type diabete patient control', 'daily dose', 'case series', 'alternateday dose', 'linagliptin']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911851/
Google Scholar Link : https://scholar.google.com/scholar?cites=10305504598411497162&as_sdt=5,34&sciodt=0,34&hl=en&num=20